Wegovy HD Rollout: Novo Nordisk Introduces 7.2 mg Dose in US Market MD Bureau8 April 2026 7:10 PM ISTBengaluru: Novo Nordisk said on Tuesday that it has made a higher-dose version of its blockbuster weight-loss drug Wegovy available across the United...
Emcure Pharma Cuts Poviztra Price by 55%, Starting Dose Now Rs 3,999 per Month Parthika Patel4 April 2026 2:25 PM ISTNew Delhi: Emcure Pharmaceuticals Limited has announced a major price reduction of up to 55% for the starting dose of its weight management drug...
Semaglutide Improves Walking Capacity in Peripheral Artery Disease: STRIDE Trial Dr Riya Dave3 April 2026 10:00 AM ISTResearchers have found in the STRIDE trial that semaglutide significantly improved walking capacity in patients with peripheral artery disease (PAD)....
Hetero Launches Generic Semaglutide Brands Truglyx, Rolmodl, Moto G Across 75+ Countries sheeba farhat28 March 2026 8:22 PM ISTNew Delhi: Hetero has announced the export launch of its generic semaglutide portfolio, marking a significant step toward expanding access to GLP-1...
Delhi HC Bars Dr Reddy's from Selling Olymviq Over Similarity with Novo Nordisk's Ozempic Susmita Roy27 March 2026 10:16 PM ISTNew Delhi: The Delhi High Court on Wednesday directed Dr. Reddy's Laboratories to temporarily stop selling its diabetes drug marketed under the brand...
GLP-1 Receptor Agonists May Reduce Risk of Glaucoma: Study Dr Riya Dave27 March 2026 9:00 PM ISTResearchers have found in a narrative review that GLP-1 receptor agonists may significantly lower the risk of ocular hypertension and glaucoma,...
Semaglutide Misuse Under Watch: Telangana DCA Issues Advisory After Generic Launch Surge Susmita Roy26 March 2026 11:30 PM ISTNew Delhi: In response to the growing demand and widespread use of Semaglutide formulations following the patent expiry of innovator products in March...
Combination GLP-1 therapy shows fat mass loss while preserving lean mass in adults with obesity: Study Dr. Kamal Kant Kohli25 March 2026 9:00 PM ISTA recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that blocks activin signaling...
Dr Reddy's Labs Gets SEC Nod to Manufacture, Market Oral Semaglutide Tablets Susmita Roy25 March 2026 8:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has recommended granting permission to Dr....
GLP-1 Drugs Improve Metabolic Outcomes in Cushing's Syndrome Without Hormonal Harm: Study Dr Riya Dave24 March 2026 8:45 AM ISTResearchers have discovered in a new study that among patients with Cushing's syndrome, treatment with GLP-1 drugs led to significant weight loss and...
Weight Loss Drugs in Early Pregnancy Linked to Premature Birth Risk in Diabetics: Study Dr. Kamal Kant Kohli23 March 2026 8:30 PM ISTWeight loss drugs have been linked to an increased risk of premature births among women who took them inadvertently just before or during early...
USV Launches USEMA - DCGI-Approved Injectable Semaglutide for Type 2 Diabetes Dr. Bhumika Maikhuri21 March 2026 11:02 AM ISTUSV Private Limited, a leading name in diabetes care, has announced the launch of USEMA, its semaglutide injection, for the management of Type 2...
